Products BTX 1503 + Vehicle
BTX 1503 + Vehicle Phase 2 Completed ⚡ Active Jun 26, 2018 → Sep 5, 2019
About BTX 1503 + Vehicle BTX 1503 + Vehicle is a phase 2 stage product being developed by Botanix Pharmaceuticals for Acne Vulgaris. The current trial status is completed. This product is registered under clinical trial identifier NCT03573518. Target conditions include Acne Vulgaris.
Clinical Trials (1) NCT ID Phase Status Start Completion Indication NCT03573518 Phase 2 Completed Jun 26, 2018 Sep 5, 2019 Acne Vulgaris
Product Company Stage Hype Score Olumacostat Glasaretil Gel, 5.0% Eli Lilly Phase 3 HT-001 2% Topical Gel + HT-001 1% Topical Gel + HT-001 0.5% Topical Gel + HT-001 Placebo Hoth Therapeutics Phase 2 Trifarotene Cream 0.005% + AKLIEF® Cream (Trifarotene 0.005%) US REFERENCE LISTED DRUG + AKLIEF® Cream (Trifarotene 50 mcg/g) CANADIAN REFERENCE PRODUCT + Placebo Sun Pharmaceutical Phase 1 Tretinoin Gel Microsphere, 0.1% + RETIN-A MICRO® (Tretinoin) Gel Microsphere, 0.1% + Placebo Control Sun Pharmaceutical Phase 1 Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/2.5% + Acanya® Gel, 1.2%/2.5% + Vehicle of test product Sun Pharmaceutical Phase 1 Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel + Duac® Topical Gel + Placebo Topical Gel Sun Pharmaceutical Phase 1 Adapalene Gel 0.1% + Placebo Control + Differin® Gel (Adapalene 0.1%, Galderma) Sun Pharmaceutical Phase 1 Trifarotene Cream 0.005% + Placebo + AKLIEF® Cream (Trifarotene 0.005%, Galderma Laboratories) Sun Pharmaceutical Phase 1 Adapalene/BP gel, 0.3%/2.5% + EPIDUO® FORTE + Placebo Sun Pharmaceutical Phase 1 ADPS topical product + Placebo Control Sun Pharmaceutical Phase 2 Isotretinoin Sun Pharmaceutical Approved Winlevi (Clascoterone) cream 1% Sun Pharmaceutical Approved Adapalene Gel 0.3% + Differin® + Placebo Sun Pharmaceutical Phase 1 CLPG Topical Gel 1% + Clindamycin + Placebo Sun Pharmaceutical Phase 1 Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% + Epiduo® Gel + Placebo Sun Pharmaceutical Phase 1 Test. + Aczone Gel 5% + Placebo Sun Pharmaceutical Phase 1 Clindamycin and Benzoyl Peroxide Gel 1%5% + BenzaClin® Topical Gel + Placebo Sun Pharmaceutical Phase 1 Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% + Onexton™ Gel + Placebo Sun Pharmaceutical Phase 1 Clindamycin Phosphate + Clindamycin Phosphate RLD + Placebos Sun Pharmaceutical Phase 1 Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% + CABTREO Topical Gel + Placebo Control Sun Pharmaceutical Phase 1
Other Products from Botanix Pharmaceuticals Sofpironium Bromide, 15% + Vehicle Phase 3
Sofpironium Bromide Gel, 15% + Vehicle Phase 3
Sofpironium Bromide Gel, 5% + Sofpironium Bromide Gel, 15% Phase 3
BBI-4000 gel, 5% + BBI-4000 gel, 10% + BBI-4000 gel, 15% + Vehicle (Placebo) Phase 2
BBI-4000 Gel, 5% + BBI-4000 Gel, 10% + BBI-4000 Gel, 15% + Vehicle Phase 2